B-Seed is a venture capital firm that focuses on early-stage investments in innovative Israeli technology companies. Their team consists of experienced professionals from various fields, including information technology, engineering, biotechnology, manufacturing, and logistics. They are supported by partners from well-known patent and accounting firms. B-Seed aims to exit their investments within a few subsequent funding rounds to maximize returns for their investors. They have offices in Tel Aviv and New York City, and their investment fund, BioMedical Fund 61, specifically targets the healthcare sector. B-Seed caters to both accredited and non-accredited investors.